RocketTickers

Supernus Announces Positive Results from Phase III Study For SPN

NASDAQ:SUPN   Supernus Pharmaceuticals, Inc
SUPN: Supernus Pharmaceuticals , Inc.
2018-12-20 07:00:00
Supernus Announces Positive Results from Phase III Study For SPN-812 in Adolescents with ADHD
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.